For example, loss of the normal function of TRIM19/PML through translocation or E6AP-mediated degradation is implicated in the pathogenesis of APL, B-ALL and lymphoma, whereas in CML low TRIM19 expression correlates with improved overall survival. The gene discussed is UBE3A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.